The current study revealed that eIF6-related signaling pathways activated in HCC were enriched in ribosome biogenesis, cell cycle and mTOR-related cancer signaling pathway, which may stimulate tumor proliferation and invasion. The gene discussed is EIF6; the disease is hepatocellular carcinoma.